Dr. Vierling is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6620 Main St
Houston, TX 77030Phone+1 713-798-2500Fax+1 713-798-2505
Summary
- Dr. John Vierling is a gastroenterologist in Houston, TX and is affiliated with Baylor St. Luke's Medical Center. He received his medical degree from Stanford University School of Medicine and has been in practice 45 years. He specializes in hepatology & liver transplantation and is experienced in general gastroenterology, hepatology, transplant hepatology, and biliary tract disease.
Education & Training
- University of California (San Francisco)Fellowship, Gastroenterology, 1977 - 1978
- National Institutes of HealthNone, USPHS Surg-04; Clinical Associate, Liver Unit, 1974 - 1977
- University of RochesterResidency, Internal Medicine, 1972 - 1974
- Stanford University School of MedicineClass of 1972
Certifications & Licensure
- CA State Medical License 1975 - 2025
- TX State Medical License 2007 - 2025
- CO State Medical License 1979 - 1993
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Who's Who in the World Marquis, 2015-2023
- America's Top Doctors Castle Connolly, 2002-2023
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Clinical Trials
- BreathID Multi-center HCV Liver Breath Test Study Start of enrollment: 2006 Jul 01
- LCP-Tacro vs. Azathioprine for the Treatment of Autoimmune Hepatitis Start of enrollment: 2007 Dec 01
- BreathID 13C-Methacetin Breath Test for Detecting Cirrhosis Start of enrollment: 2008 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Lessons From COBALT: Will the Bell Also Toll for Thee?John Moore Vierling, Paul J Pockros
The American Journal of Gastroenterology. 2024-10-02 - Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA).Virginia C Clark, Charlie Strange, Pavel Strnad, Antonio J Sanchez, Paul Kwo
Gastroenterology. 2024-10-01 - 2 citationsPrimary biliary cholangitis.Atsushi Tanaka, Xiong Ma, Atsushi Takahashi, John M Vierling
Lancet. 2024-09-14
Journal Articles
- Trends in Outcomes for Marginal Allografts in Liver TransplantJohn M Vierling, Abbas Rana, JAMA Surgery
Other
- Overview of immunosuppression in adult liver transplantationVierling JM, Sussman NL
http://www.uptodate.com/contents/overview-of-immunosuppression-in-adult-liver-transplantation
UpToDate, Wolters Kluwer Health - 2013-03-12
Press Mentions
- Can Ramadan Fasting Hold the Key to Improved Health? A Houston Doctor Aims to Find OutMay 12th, 2020
- Athenex Announces Expansion of Board of DirectorsMarch 21st, 2019
- FDA Grants Accelerated Approval to Intercept's OcalivaJune 1st, 2016
- Join now to see all
Grant Support
- Hepatic Lesions In Murine Chronic Graft VS Host DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2001
- Hepatic Lesions In Murine Chronic Graft-Vs-Host DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases1989–1991
- Hepatic Lesions In Murine Chronic Graft-Vs-Host DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1989
Professional Memberships
- Member
- Member
- American Association for the Study of Liver DiseasesFellow
- Fellow
- European Association for the Study of LiverMember
- American Clinical and Climatological AssociationMember
- American Liver FoundationMember, National Medical Advisory Board
- American Liver FoundationMember, Selection Committee for the Scientific Achievement Award
- American Association for the Study of Liver DiseasesFoundation Fundraising Committee
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: